Results 61 to 70 of about 14,134 (231)
Clinical, Cosmetic and Investigational Dermatology, 2022 Yuqi Chu, Taoming Liu, Juan Bai, Hong Fang, Jianjun Qiao Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence: Jianjun Qiao, Department of Dermatology, The ...
Chu Y, Liu T, Bai J, Fang H, Qiao J
doaj
Infection and Drug Resistance, 2023 Qingqing Xu,1 Xiaochen Wang,2 Anbo Yang,3 Guo Wei1 1Department of Dermato-Venereology, the Second Hospital of Shandong University, Jinan, 250033, People’s Republic of China; 2Clinical Laboratory of Qingdao Municipal Hospital, Qingdao, 266000, People’s ...
Xu Q, Wang X, Yang A, Wei G
doaj
Pustulotic arthro-osteitis (Sonozaki Syndrome)
Indian Journal of Dermatology, 2011 Pustulotic arthro-osteitis, first described by Sonozaki, is a relatively rare disorder. Its prevalence is however probably underestimated in dermatological literature. Early recognition of the signs can prevent misdiagnosis. We describe a Turkish patient
Ozlem Su +4 more
doaj +1 more source
Assessing the Effect of Adalimumab in Granuloma Annulare: A Case Series and Literature Review
JEADV Clinical Practice, EarlyView.ABSTRACT Granuloma annulare (GA) is a benign granulomatous skin disorder for which standardized treatment guidelines are lacking due to limited evidence. Adalimumab, a TNF‐α inhibitor, shows promise as a therapeutic option due to its potential to disrupt GA granulomas.
Adriana Caixinha Valorenzos +2 more
wiley +1 more source
Efficacy and safety of brodalumab in palmoplantar pustulosis: A 68‐week randomized Phase 3 trial
Journal of the European Academy of Dermatology and Venereology, EarlyView.This open‐label study is a continuation of the 16‐week double‐blind, Phase 3 trial assessing the efficacy and safety of brodalumab 210 mg subcutaneously, till a 68‐week extension period. Continued improvement was seen in the PPPASI 50/75/90 responses, PPPSI scores, PGA 0/1 responses and DLQI. Abstract Background The efficacy and safety of brodalumab in
Masamoto Murakami +6 more
wiley +1 more source
Manifestaciones cutáneas de las enfermedades de tiroides: Revisión [PDF]
, 2017 Los trastornos del tiroides son muy prevalentes en la práctica clínica. Un estudio epidemiológico europeo destaca que casi la mitad de los pacientes con enfermedad tiroidea permanecen sin diagnosticar.
Lucas San Atanasio, Delia de
core
Postpartum lumbopelvic pain could be SAPHO syndrome: a case report
Frontiers in ImmunologyBackgroundSynovitis–acne–pustulosis–hyperostosis–osteitis (SAPHO) syndrome is a rare autoimmune disorder. The involvement of spinal and sacroiliac joint in SAPHO syndrome closely resembles the manifestations of postpartum lumbopelvic pain (LPP).Case ...
Zheng Weiwei, Zhang Junhong, Zhang Rong
doaj +1 more source
Analysis of the human diseasome reveals phenotype modules across common, genetic, and infectious diseases [PDF]
, 2014 Phenotypes are the observable characteristics of an organism arising from its response to the environment. Phenotypes associated with engineered and natural genetic variation are widely recorded using phenotype ontologies in model organisms, as are signs
Gkoutos, Georgios V +2 more
core +2 more sources
Pediatric Dermatology, EarlyView.ABSTRACT Erythrokeratodermia cardiomyopathy (EKC) syndrome is a rare autosomal dominant disorder characterized by generalized erythrokeratoderma and progressive dilated cardiomyopathy, caused by pathogenic variants in the SR6 domain of desmoplakin (DSP).
Sepideh Hamzehlou +7 more
wiley +1 more source
Real-world experience of the efficacy and safety of guselkumab 100 mg in patients with palmoplantar pustulosis in Korea: A retrospective single-center study [PDF]
JAAD InternationalMin Kyung Cho, MD, Dong Hyun Kim, MD
doaj +2 more sources